APO Research
Talk to an analyst

APO RESEARCH · REPORT

RNAi Therapeutics

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global RNAi Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025170 pages

Choose your research edition.

Industry ResearchRNAi Therapeutics Industry Research Report 2026100 pages · $2,950 USDIndustry Growth & TrendsGlobal RNAi Therapeutics Industry Growth and Trends Forecast to 203263 pages · $3,450 USDMarket StructureGlobal RNAi Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032170 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal RNAi Therapeutics Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal RNAi Therapeutics Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global RNAi Therapeutics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for RNAi Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for RNAi Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for RNAi Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for RNAi Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of RNAi Therapeutics include Novartis and Alnylam Pharmaceuticals among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global RNAi Therapeutics market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of RNAi Therapeutics and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents RNAi Therapeutics revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the RNAi Therapeutics market size, projected growth trends, production technologies, key applications, and end-use industries.

RNAi Therapeutics Segment by Company

Novartis

Alnylam Pharmaceuticals

RNAi Therapeutics Segment by Type

Subcutaneous Injection

Intravenous Infusion

RNAi Therapeutics Segment by Application

Cancer

Cardiovascular Disease

Genetic Disorder

Other

RNAi Therapeutics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global RNAi Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of RNAi Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of RNAi Therapeutics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of RNAi Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global RNAi Therapeutics industry.

Chapter 3: Detailed analysis of RNAi Therapeutics companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, RNAi Therapeuticsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global RNAi Therapeutics Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Subcutaneous Injection Table 3. Key Players of Intravenous Infusion Table 4. Global RNAi Therapeutics Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Cancer Table 6. Key Players of Cardiovascular Disease Table 7. Key Players of Genetic Disorder Table 8. Key Players of Other Table 9. Global RNAi Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global RNAi Therapeutics Market Size by Region (2021-2026) & (US$ Million) Table 11. Global RNAi Therapeutics Market Share by Region (2021-2026) Table 12. Global RNAi Therapeutics Market Size by Region (2027-2032) & (US$ Million) Table 13. Global RNAi Therapeutics Market Share by Region (2027-2032) Table 14. RNAi Therapeutics Industry Trends Table 15. RNAi Therapeutics Industry Drivers Table 16. RNAi Therapeutics Industry Opportunities and Challenges Table 17. RNAi Therapeutics Industry Restraints Table 18. Global RNAi Therapeutics Revenue by Company (US$ Million) & (2021-2026) Table 19. Global RNAi Therapeutics Revenue Market Share by Company (2021-2026) Table 20. Global RNAi Therapeutics Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global RNAi Therapeutics Key Company Head Office and Area Served Table 22. Global RNAi Therapeutics Company, Product Type & Application Table 23. Global RNAi Therapeutics Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global RNAi Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global RNAi Therapeutics Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global RNAi Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 28. Global RNAi Therapeutics Market Size by Type (2027-2032) & (US$ Million) Table 29. Global RNAi Therapeutics Revenue Market Share by Type (2021-2026) Table 30. Global RNAi Therapeutics Revenue Market Share by Type (2027-2032) Table 31. Global RNAi Therapeutics Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global RNAi Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 33. Global RNAi Therapeutics Market Size by Application (2027-2032) & (US$ Million) Table 34. Global RNAi Therapeutics Revenue Market Share by Application (2021-2026) Table 35. Global RNAi Therapeutics Revenue Market Share by Application (2027-2032) Table 36. Novartis Company Information Table 37. Novartis Business Overview Table 38. Novartis RNAi Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Novartis RNAi Therapeutics Product Portfolio Table 40. Novartis Recent Development Table 41. Alnylam Pharmaceuticals Company Information Table 42. Alnylam Pharmaceuticals Business Overview Table 43. Alnylam Pharmaceuticals RNAi Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Alnylam Pharmaceuticals RNAi Therapeutics Product Portfolio Table 45. Alnylam Pharmaceuticals Recent Development Table 46. North America RNAi Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 47. North America RNAi Therapeutics Market Size by Type (2027-2032) & (US$ Million) Table 48. North America RNAi Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 49. North America RNAi Therapeutics Market Size by Application (2027-2032) & (US$ Million) Table 50. North America RNAi Therapeutics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 51. North America RNAi Therapeutics Market Size by Country (2021-2026) Table 52. North America RNAi Therapeutics Market Size by Country (2027-2032) Table 53. Europe RNAi Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 54. Europe RNAi Therapeutics Market Size by Type (2027-2032) & (US$ Million) Table 55. Europe RNAi Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 56. Europe RNAi Therapeutics Market Size by Application (2027-2032) & (US$ Million) Table 57. Europe RNAi Therapeutics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 58. Europe RNAi Therapeutics Market Size by Country (2021-2026) Table 59. Europe RNAi Therapeutics Market Size by Country (2027-2032) Table 60. China RNAi Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 61. China RNAi Therapeutics Market Size by Type (2027-2032) & (US$ Million) Table 62. China RNAi Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 63. China RNAi Therapeutics Market Size by Application (2027-2032) & (US$ Million) Table 64. Asia RNAi Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 65. Asia RNAi Therapeutics Market Size by Type (2027-2032) & (US$ Million) Table 66. Asia RNAi Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 67. Asia RNAi Therapeutics Market Size by Application (2027-2032) & (US$ Million) Table 68. Asia RNAi Therapeutics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 69. Asia RNAi Therapeutics Market Size by Country (2021-2026) Table 70. Asia RNAi Therapeutics Market Size by Country (2027-2032) Table 71. South America, Middle East & Africa RNAi Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 72. South America, Middle East & Africa RNAi Therapeutics Market Size by Type (2027-2032) & (US$ Million) Table 73. South America, Middle East & Africa RNAi Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 74. South America, Middle East & Africa RNAi Therapeutics Market Size by Application (2027-2032) & (US$ Million) Table 75. South America, Middle East & Africa RNAi Therapeutics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 76. South America, Middle East & Africa RNAi Therapeutics Market Size by Country (2021-2026) Table 77. South America, Middle East & Africa RNAi Therapeutics Market Size by Country (2027-2032) Table 78. Research Programs/Design for This Report Table 79. Authors List of This Report Table 80. Secondary Sources Table 81. Primary Sources List of Figures Figure 1. RNAi Therapeutics Product Image Figure 2. Global RNAi Therapeutics Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global RNAi Therapeutics Market Share by Type: 2025 VS 2032 Figure 4. Subcutaneous Injection Image Figure 5. Intravenous Infusion Image Figure 6. Global RNAi Therapeutics Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global RNAi Therapeutics Market Share by Application: 2025 VS 2032 Figure 8. Cancer Image Figure 9. Cardiovascular Disease Image Figure 10. Genetic Disorder Image Figure 11. Other Image Figure 12. Global RNAi Therapeutics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global RNAi Therapeutics Market Size (2021-2032) & (US$ Million) Figure 14. Global RNAi Therapeutics Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global RNAi Therapeutics Market Share by Players in 2025 Figure 17. Global Top 5 and 10 RNAi Therapeutics Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global RNAi Therapeutics Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global RNAi Therapeutics Revenue Market Share by Type (2021-2032) Figure 21. Global RNAi Therapeutics Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global RNAi Therapeutics Revenue Market Share by Application (2021-2032) Figure 23. North America RNAi Therapeutics Market Size (2021-2032) & (US$ Million) Figure 24. North America RNAi Therapeutics Market Share by Type (2021-2032) Figure 25. North America RNAi Therapeutics Market Share by Application (2021-2032) Figure 26. North America RNAi Therapeutics Market Share by Country (2021-2032) Figure 27. United States RNAi Therapeutics Market Size (2021-2032) & (US$ Million) Figure 28. Canada RNAi Therapeutics Market Size (2021-2032) & (US$ Million) Figure 29. Mexico RNAi Therapeutics Market Size (2021-2032) & (US$ Million) Figure 30. Europe RNAi Therapeutics Market Size (2021-2032) & (US$ Million) Figure 31. Europe RNAi Therapeutics Market Share by Type (2021-2032) Figure 32. Europe RNAi Therapeutics Market Share by Application (2021-2032) Figure 33. Europe RNAi Therapeutics Market Share by Country (2021-2032) Figure 34. Germany RNAi Therapeutics Market Size (2021-2032) & (US$ Million) Figure 35. France RNAi Therapeutics Market Size (2021-2032) & (US$ Million) Figure 36. U.K. RNAi Therapeutics Market Size (2021-2032) & (US$ Million) Figure 37. Italy RNAi Therapeutics Market Size (2021-2032) & (US$ Million) Figure 38. Russia RNAi Therapeutics Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries RNAi Therapeutics Market Size (2021-2032) & (US$ Million) Figure 40. China RNAi Therapeutics Market Size (2021-2032) & (US$ Million) Figure 41. China RNAi Therapeutics Market Share by Type (2021-2032) Figure 42. China RNAi Therapeutics Market Share by Application (2021-2032) Figure 43. Asia RNAi Therapeutics Market Size (2021-2032) & (US$ Million) Figure 44. Asia RNAi Therapeutics Market Share by Type (2021-2032) Figure 45. Asia RNAi Therapeutics Market Share by Application (2021-2032) Figure 46. Asia RNAi Therapeutics Market Share by Country (2021-2032) Figure 47. Japan RNAi Therapeutics Market Size (2021-2032) & (US$ Million) Figure 48. South Korea RNAi Therapeutics Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan RNAi Therapeutics Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia RNAi Therapeutics Market Size (2021-2032) & (US$ Million) Figure 51. India RNAi Therapeutics Market Size (2021-2032) & (US$ Million) Figure 52. Australia RNAi Therapeutics Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa RNAi Therapeutics Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa RNAi Therapeutics Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa RNAi Therapeutics Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa RNAi Therapeutics Market Share by Country (2021-2032) Figure 57. Brazil RNAi Therapeutics Market Size (2021-2032) & (US$ Million) Figure 58. South Africa RNAi Therapeutics Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia RNAi Therapeutics Market Size (2021-2032) & (US$ Million) Figure 60. Turkey RNAi Therapeutics Market Size (2021-2032) & (US$ Million) Figure 61. Argentina RNAi Therapeutics Market Size (2021-2032) & (US$ Million) Figure 62. UAE RNAi Therapeutics Market Size (2021-2032) & (US$ Million) Figure 63. Egypt RNAi Therapeutics Market Size (2021-2032) & (US$ Million) Figure 64. Chile RNAi Therapeutics Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Subcutaneous Injection
  • Intravenous Infusion
Applications
  • Cancer
  • Cardiovascular Disease
  • Genetic Disorder
  • Other
Companies covered
  • Novartis
  • Alnylam Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global RNAi Therapeutics Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Subcutaneous Injection
  5. 1.2.3 Intravenous Infusion
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global RNAi Therapeutics Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Cancer
  9. 1.3.3 Cardiovascular Disease
  10. 1.3.4 Genetic Disorder
  11. 1.3.5 Other
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global RNAi Therapeutics Growth Trends by Region
  14. 1.5.1 Global RNAi Therapeutics Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 RNAi Therapeutics Market Size by Region (2021-2026)
  16. 1.5.3 RNAi Therapeutics Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global RNAi Therapeutics Market Dynamics
  1. 2.1 RNAi Therapeutics Industry Trends
  2. 2.2 RNAi Therapeutics Industry Drivers
  3. 2.3 RNAi Therapeutics Industry Opportunities and Challenges
  4. 2.4 RNAi Therapeutics Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global RNAi Therapeutics Revenue by Company (2021-2026)
  2. 3.2 Global RNAi Therapeutics Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global RNAi Therapeutics Key Company Head office and Area Served
  4. 3.4 Global RNAi Therapeutics Company, Product Type & Application
  5. 3.5 Global RNAi Therapeutics Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global RNAi Therapeutics Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 RNAi Therapeutics Players Market Share by Revenue in 2025
  9. 3.6.3 2025 RNAi Therapeutics Tier 1, Tier 2, and Tier 3
4 RNAi Therapeutics Market by Type
  1. 4.1 Global RNAi Therapeutics Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global RNAi Therapeutics Market Size by Type (2021-2032)
  3. 4.3 Global RNAi Therapeutics Market Size Share by Type (2021-2032)
5 RNAi Therapeutics Market by Application
  1. 5.1 Global RNAi Therapeutics Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global RNAi Therapeutics Market Size by Application (2021-2032)
  3. 5.3 Global RNAi Therapeutics Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Novartis
  2. 6.1.1 Novartis Company Information
  3. 6.1.2 Novartis Business Overview
  4. 6.1.3 Novartis RNAi Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Novartis RNAi Therapeutics Product Portfolio
  6. 6.1.5 Novartis Recent Developments
  7. 6.2 Alnylam Pharmaceuticals
  8. 6.2.1 Alnylam Pharmaceuticals Company Information
  9. 6.2.2 Alnylam Pharmaceuticals Business Overview
  10. 6.2.3 Alnylam Pharmaceuticals RNAi Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Alnylam Pharmaceuticals RNAi Therapeutics Product Portfolio
  12. 6.2.5 Alnylam Pharmaceuticals Recent Developments
7 North America
  1. 7.1 North America RNAi Therapeutics Market Size (2021-2032)
  2. 7.2 North America RNAi Therapeutics Market Size by Type
  3. 7.2.1 North America RNAi Therapeutics Market Size by Type (2021-2026)
  4. 7.2.2 North America RNAi Therapeutics Market Size by Type (2027-2032)
  5. 7.2.3 North America RNAi Therapeutics Market Share by Type (2021-2032)
  6. 7.3 North America RNAi Therapeutics Market Size by Application
  7. 7.3.1 North America RNAi Therapeutics Market Size by Application (2021-2026)
  8. 7.3.2 North America RNAi Therapeutics Market Size by Application (2027-2032)
  9. 7.3.3 North America RNAi Therapeutics Market Share by Application (2021-2032)
  10. 7.4 North America RNAi Therapeutics Market Size by Country
  11. 7.4.1 North America RNAi Therapeutics Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America RNAi Therapeutics Market Size by Country (2021-2026)
  13. 7.4.3 North America RNAi Therapeutics Market Size by Country (2027-2032)
  14. 7.4.4 North America RNAi Therapeutics Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe RNAi Therapeutics Market Size (2021-2032)
  2. 8.2 Europe RNAi Therapeutics Market Size by Type
  3. 8.2.1 Europe RNAi Therapeutics Market Size by Type (2021-2026)
  4. 8.2.2 Europe RNAi Therapeutics Market Size by Type (2027-2032)
  5. 8.2.3 Europe RNAi Therapeutics Market Share by Type (2021-2032)
  6. 8.3 Europe RNAi Therapeutics Market Size by Application
  7. 8.3.1 Europe RNAi Therapeutics Market Size by Application (2021-2026)
  8. 8.3.2 Europe RNAi Therapeutics Market Size by Application (2027-2032)
  9. 8.3.3 Europe RNAi Therapeutics Market Share by Application (2021-2032)
  10. 8.4 Europe RNAi Therapeutics Market Size by Country
  11. 8.4.1 Europe RNAi Therapeutics Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe RNAi Therapeutics Market Size by Country (2021-2026)
  13. 8.4.3 Europe RNAi Therapeutics Market Size by Country (2027-2032)
  14. 8.4.4 Europe RNAi Therapeutics Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China RNAi Therapeutics Market Size (2021-2032)
  2. 9.2 China RNAi Therapeutics Market Size by Type
  3. 9.2.1 China RNAi Therapeutics Market Size by Type (2021-2026)
  4. 9.2.2 China RNAi Therapeutics Market Size by Type (2027-2032)
  5. 9.2.3 China RNAi Therapeutics Market Share by Type (2021-2032)
  6. 9.3 China RNAi Therapeutics Market Size by Application
  7. 9.3.1 China RNAi Therapeutics Market Size by Application (2021-2026)
  8. 9.3.2 China RNAi Therapeutics Market Size by Application (2027-2032)
  9. 9.3.3 China RNAi Therapeutics Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia RNAi Therapeutics Market Size (2021-2032)
  2. 10.2 Asia RNAi Therapeutics Market Size by Type
  3. 10.2.1 Asia RNAi Therapeutics Market Size by Type (2021-2026)
  4. 10.2.2 Asia RNAi Therapeutics Market Size by Type (2027-2032)
  5. 10.2.3 Asia RNAi Therapeutics Market Share by Type (2021-2032)
  6. 10.3 Asia RNAi Therapeutics Market Size by Application
  7. 10.3.1 Asia RNAi Therapeutics Market Size by Application (2021-2026)
  8. 10.3.2 Asia RNAi Therapeutics Market Size by Application (2027-2032)
  9. 10.3.3 Asia RNAi Therapeutics Market Share by Application (2021-2032)
  10. 10.4 Asia RNAi Therapeutics Market Size by Country
  11. 10.4.1 Asia RNAi Therapeutics Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia RNAi Therapeutics Market Size by Country (2021-2026)
  13. 10.4.3 Asia RNAi Therapeutics Market Size by Country (2027-2032)
  14. 10.4.4 Asia RNAi Therapeutics Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa RNAi Therapeutics Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa RNAi Therapeutics Market Size by Type
  3. 11.2.1 South America, Middle East & Africa RNAi Therapeutics Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa RNAi Therapeutics Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa RNAi Therapeutics Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa RNAi Therapeutics Market Size by Application
  7. 11.3.1 South America, Middle East & Africa RNAi Therapeutics Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa RNAi Therapeutics Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa RNAi Therapeutics Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa RNAi Therapeutics Market Size by Country
  11. 11.4.1 South America, Middle East & Africa RNAi Therapeutics Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa RNAi Therapeutics Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa RNAi Therapeutics Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa RNAi Therapeutics Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst